Literature DB >> 23103003

Hybrid coronary revascularization using robotic totally endoscopic surgery: perioperative outcomes and 5-year results.

Johannes O Bonatti1, David Zimrin, Eric J Lehr, Mark Vesely, Zachary N Kon, Brody Wehman, Andreas R de Biasi, Benedikt Hofauer, Felix Weidinger, Thomas Schachner, Nikolaos Bonaros, Guy Friedrich.   

Abstract

BACKGROUND: Hybrid coronary revascularization combines minimally invasive coronary artery bypass grafting and catheter-based interventions. This treatment option represents a viable alternative to both open multivessel coronary bypass surgery through sternotomy and multivessel percutaneous coronary intervention. The surgical component of hybrid coronary intervention can be offered in a completely endoscopic fashion using robotic technology. We report on one of the largest series to date.
METHODS: From 2001 to 2011, 226 patients (age, 61 years [range, 31 to 90 years]; 77.0% male; EuroSCORE, 2 [range, 0 to 13]) underwent hybrid coronary interventions on an intention-to-treat basis. Robotically assisted procedures were performed using the daVinci, daVinci S, and daVinci Si surgical telemanipulation systems (Intuitive Surgical, Inc, Sunnyvale, CA) and included 147 single, 72 double, and 7 triple endoscopic coronary artery bypass grafting procedures. Surgery was carried out first in 160 cases (70.8%), percutaneous coronary intervention was carried out first in 38 cases (16.8%), and 28 patients underwent simultaneous operations in a hybrid operating room (12.4%). Drug-eluting stents were used in 70.0% of the patients.
RESULTS: Hospital mortality was 3 of 226 patients (1.3%), and hospital stay averaged 6 days (range, 3 to 54 days). Patients walked outside 7 days (range, 3 to 97 days) postoperatively and performed general household work 14 days (range, 7 to 180 days) postoperatively. Full activity was resumed at 42 days (range, 7 to 720 days). Five-year survival was 92.9%, and 5-year freedom from major adverse cardiac and cerebral events was 75.2%. At 5 years, 2.7% of bypass grafts and 14.2% of percutaneous coronary intervention targets needed reintervention.
CONCLUSIONS: Robotically assisted hybrid coronary intervention enables surgical treatment of multivessel coronary artery disease with minimal trauma. Perioperative results and intermediate-term outcomes meet the standards of open coronary artery bypass grafting. Recovery time is short, and reintervention rates are acceptable.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23103003     DOI: 10.1016/j.athoracsur.2012.05.041

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

Review 1.  Robotically assisted totally endoscopic coronary artery bypass surgery.

Authors:  Leonardo Secchin Canale; Stephanie Mick; Tomislav Mihaljevic; Ravi Nair; Johannes Bonatti
Journal:  J Thorac Dis       Date:  2013-11       Impact factor: 2.895

Review 2.  Robot-assisted cardiac surgery.

Authors:  Norihiko Ishikawa; Go Watanabe
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-07-02       Impact factor: 1.520

3.  The role of robotics in cardiac surgery: a systematic review.

Authors:  Ilias P Doulamis; Eleftherios Spartalis; Nikolaos Machairas; Dimitrios Schizas; Dimitrios Patsouras; Michael Spartalis; Diamantis I Tsilimigras; Demetrios Moris; Dimitrios C Iliopoulos; Aspasia Tzani; Dimitrios Dimitroulis; Nikolaos I Nikiteas
Journal:  J Robot Surg       Date:  2018-09-25

Review 4.  Robotic technology in cardiovascular medicine.

Authors:  Johannes Bonatti; George Vetrovec; Celia Riga; Oussama Wazni; Petr Stadler
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

5.  Hybrid coronary revascularization for the treatment of multivessel coronary artery disease.

Authors:  Michael O Kayatta; Michael E Halkos; John D Puskas
Journal:  Ann Cardiothorac Surg       Date:  2018-07

Review 6.  Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease.

Authors:  Ralf E Harskamp; Zhe Zheng; John H Alexander; Judson B Williams; Ying Xian; Michael E Halkos; J Matthew Brennan; Robbert J de Winter; Peter K Smith; Renato D Lopes
Journal:  Ann Thorac Surg       Date:  2013-12       Impact factor: 4.330

7.  Long-term results after robotically assisted coronary bypass surgery.

Authors:  Johannes Bonatti; Jehad Ramahi; Faisal Hasan; Ahmad Edris; Thomas Bartel; Ravi Nair; Murat Tuzcu; Rakesh Suri; Tomislav Mihaljevic
Journal:  Ann Cardiothorac Surg       Date:  2016-11

Review 8.  Robotic totally endoscopic coronary artery bypass grafting (TECAB)-placement of bilateral internal mammary arteries to the left ventricle.

Authors:  Johannes Bonatti; Antti Vento; Nikolaos Bonaros; Mahmoud Traina; Eric Lehr
Journal:  Ann Cardiothorac Surg       Date:  2016-11

9.  Hybrid coronary revascularization: present indications and future perspective.

Authors:  Konstantinos Voudris; Dimitrios V Avgerinos; Dmitriy Feldman; Konstantinos Charitakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

10.  Systematic review of robotic-assisted, totally endoscopic coronary artery bypass grafting.

Authors:  Michael Seco; J James B Edelman; Tristan D Yan; Michael K Wilson; Paul G Bannon; Michael P Vallely
Journal:  Ann Cardiothorac Surg       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.